Background: Disrupted gait has been associated with an increased risk of frailty, disability, and death, but the causal molecular pathways are not well understood. Sphingolipids, including ceramides, are associated with multiple age-related diseases. Ceramides promote atrophy, necrosis, and proteolysis in cellular and animal models, and ceramide C16:0 levels are negatively correlated with muscle mass in men. However, there is a paucity of evidence examining sphingolipids and physical function. Methods: We examined the cross-sectional association between plasma ceramides, sphingosine-1-phosphate (S1P), and ceramide/S1P ratios and gait, a robust measure of physical function, in 340 clinically normal participants aged 70 years and older enrolled in the Mayo Clinic Study of Aging. GAITRite® instrumentation was used to measure gait speed, cadence, step width, double support time, and intra-individual stride time variability. Based on previous studies, we hypothesized that higher plasma levels of ceramide C16:0 would be associated with worse gait. Results: Multivariable adjusted linear regression models revealed that higher levels of ceramide C16:0 were associated with slower gait speed, decreased cadence, and increased double support time. Conclusions: These results suggest an association between plasma ceramide C16:0 and physical function. Longitudinal studies are needed to determine whether elevated ceramide C16:0 can be utilized as a prognostic marker for functional decline.
Background: Disrupted gait has been associated with an increased risk of frailty, disability, and death, but the causal molecular pathways are not well understood. Sphingolipids, including ceramides, are associated with multiple age-related diseases. Ceramides promote atrophy, necrosis, and proteolysis in cellular and animal models, and ceramide C16:0 levels are negatively correlated with muscle mass in men. However, there is a paucity of evidence examining sphingolipids and physical function. Methods: We examined the cross-sectional association between plasma ceramides, sphingosine-1-phosphate (S1P), and ceramide/S1P ratios and gait, a robust measure of physical function, in 340 clinically normal participants aged 70 years and older enrolled in the Mayo Clinic Study of Aging. GAITRite® instrumentation was used to measure gait speed, cadence, step width, double support time, and intra-individual stride time variability. Based on previous studies, we hypothesized that higher plasma levels of ceramide C16:0 would be associated with worse gait. Results: Multivariable adjusted linear regression models revealed that higher levels of ceramide C16:0 were associated with slower gait speed, decreased cadence, and increased double support time. Conclusions: These results suggest an association between plasma ceramide C16:0 and physical function. Longitudinal studies are needed to determine whether elevated ceramide C16:0 can be utilized as a prognostic marker for functional decline.
Authors: Hazel Huang; Takhar Kasumov; Patrick Gatmaitan; Helen M Heneghan; Sangeeta R Kashyap; Philip R Schauer; Stacy A Brethauer; John P Kirwan Journal: Obesity (Silver Spring) Date: 2011-05-05 Impact factor: 5.002
Authors: G Abellan van Kan; Y Rolland; S Andrieu; J Bauer; O Beauchet; M Bonnefoy; M Cesari; L M Donini; S Gillette Guyonnet; M Inzitari; F Nourhashemi; G Onder; P Ritz; A Salva; M Visser; B Vellas Journal: J Nutr Health Aging Date: 2009-12 Impact factor: 4.075
Authors: Zhonghao Yu; Guangju Zhai; Paula Singmann; Ying He; Tao Xu; Cornelia Prehn; Werner Römisch-Margl; Eva Lattka; Christian Gieger; Nicole Soranzo; Joachim Heinrich; Marie Standl; Elisabeth Thiering; Kirstin Mittelstraß; Heinz-Erich Wichmann; Annette Peters; Karsten Suhre; Yixue Li; Jerzy Adamski; Tim D Spector; Thomas Illig; Rui Wang-Sattler Journal: Aging Cell Date: 2012-08-27 Impact factor: 9.304
Authors: Marta Gonzalez-Freire; Ruin Moaddel; Kai Sun; Elisa Fabbri; Pingbo Zhang; Mohammed Khadeer; Norman Salem; Luigi Ferrucci; Richard D Semba Journal: J Gerontol A Biol Sci Med Sci Date: 2019-01-01 Impact factor: 6.053
Authors: Ryan O Walters; Esperanza Arias; Antonio Diaz; Emmanuel S Burgos; Fangxia Guan; Simoni Tiano; Kai Mao; Cara L Green; Yungping Qiu; Hardik Shah; Donghai Wang; Adam D Hudgins; Tahmineh Tabrizian; Valeria Tosti; David Shechter; Luigi Fontana; Irwin J Kurland; Nir Barzilai; Ana Maria Cuervo; Daniel E L Promislow; Derek M Huffman Journal: Cell Rep Date: 2018-10-16 Impact factor: 9.423
Authors: Jovia L Nierenberg; Jiang He; Changwei Li; Xiaoying Gu; Mengyao Shi; Alexander C Razavi; Xuenan Mi; Shengxu Li; Lydia A Bazzano; Amanda H Anderson; Hua He; Wei Chen; Jack M Guralnik; Jason M Kinchen; Tanika N Kelly Journal: Aging (Albany NY) Date: 2020-06-01 Impact factor: 5.682
Authors: Beom-Jun Kim; Jin Young Lee; So Jeong Park; Seung Hum Lee; Su Jung Kim; Hyun Ju Yoo; Sarah I Rivera De Pena; Meghan McGee-Lawrence; Carlos M Isales; Jung-Min Koh; Mark W Hamrick Journal: Aging (Albany NY) Date: 2019-11-01 Impact factor: 5.682